T. Wagner

pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations.

Torsten Wagner, Annette Bauer-Brandl, A. Bauer-Brandl, 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Comparison of permeation enhancing strategies for an oral factor Xa inhibitor using the Caco-2 cell monolayer model.

A. Funke, R. Lipp, T. Wagner, 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Development of a novel osmotically driven drug delivery system for weakly basic drugs.

H. Kranz, R. Lipp, C. Guthmann, 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Development of a multi particulate extended release formulation for ZK 811 752, a weakly basic drug.

H Kranz, H. Kranz, V. Le Brun, 2005, International journal of pharmaceutics.

Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations.

H. Kranz, T. Wagner, 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug.

H. Kranz, J. Reinhard, R. Lipp, 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Novel poloxamer-based nanoemulsions to enhance the intestinal absorption of active compounds.

A. Funke, R. Lipp, T. Wagner, 2007, International journal of pharmaceutics.

Development of a Multiple Unit Pellet Formulation for a Weakly Basic Drug

H. Kranz, R. Lipp, C. Guthmann, 2007, Drug development and industrial pharmacy.